Prevalence, distribution and clinical correlates of myocardial fibrosis in systemic lupus erythematosus: A cardiac magnetic resonance study

Lupus

Volumn 25, Issue 6, 2016, Pages 573-581

  Seneviratne, Martin G ^a   Grieve, S M ^a,b,c   Figtree, G A ^a,d   Garsia, R ^a,b   Celermajer, D S ^a,b,c   Adelstein, S ^a,b   Puranik, R ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c HEART RESEARCH INSTITUTE   (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

cardiovascular disease; magnetic resonance imaging; Systemic lupus erythematosus

Indexed keywords

GADOBUTROL; CONTRAST MEDIUM; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DISEASE DURATION; DISEASE SEVERITY; EXERCISE TOLERANCE; FEMALE; GROUPS BY AGE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE SEPTUM; HUMAN; MALE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE SCANNER; PREVALENCE; PRIORITY JOURNAL; REAL TIME ULTRASOUND SCANNER; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSTHORACIC ECHOCARDIOGRAPHY; TREADMILL TEST; AGE; AGED; CARDIOMYOPATHIES; COMPLICATION; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FIBROSIS; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; RISK FACTOR;

ADULT; AGE FACTORS; AGED; CARDIOMYOPATHIES; CONTRAST MEDIA; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; FIBROSIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PREVALENCE; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84963593648     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203315622275     Document Type: Article

References (37)

1. Bulkley BH, Roberts WC,. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 1975; 58: 243-264.
2. D1oria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M,. Cardiac involvement in systemic lupus erythematosus. Lupus 2005; 14: 683-686.
3. Jain D, Halushka MK,. Cardiac pathology of Systemic Lupus Erythematosus. J Clin Pathol 2009; 62: 584-592.
4. Kwong RY, Sattar H, Wu H, et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 2008; 118: 1011-1020.
5. Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003; 108: 1945-1953.
6. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48: 1977-1985.
7. Mavrogeni S, Dimitroulas T, Kitas GD,. Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis. Autoimmun Rev 2012; 12: 305-312.
8. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA,. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011; 57: 891-903.
9. Saremi F, Ashikyan O, Saggar R, Vu J, Nunez ME,. Utility of cardiac MRI for diagnosis and post-treatment follow-up of lupus myocarditis. Int J CardiovascI Imaging 2007; 23: 347-352.
10. Edwards NC, Ferro CJ, Townend JN, Steeds RP,. Myocardial disease in systemic vasculitis and autoimmune disease detected by cardiovascular magnetic resonance. Rheumatology 2007; 46: 1208-1209.
11. Abdel-Aty H, Siegle N, Natusch A, et al. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus 2008; 17: 561-567.
12. O'Neill SG, Woldman S, Bailliard F, et al. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus. Ann Rheum Dis 2009; 68: 1478-1481.
13. Kobayashi H, Giles J, Arinuma Y, Yokoe I, Hirano M, Kobayashi Y,. Cardiac magnetic resonance imaging abnormalities in patients with systemic lupus erythematosus: a preliminary report. Mod Rheumatol 2010; 20: 319-323.
14. Mavrogeni S, Bratis K, Markussis V, et al. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis. Lupus 2013; 22: 34-43.
15. Puntmann VO, D'Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circulation. Cardiovasc Imaging 2013; 6: 295-301.
16. Andre F, Santos MFB, Abdel-Aty H,. Prevalence of cardiac morphological and functional alterations in systemic lupus erythematosus patients with a low disease activity. J Cardiovasc Magnetic Res 2013; 15 (Suppl 1): 94-94.
17. Chan RH, Maron BJ, Olivotto I, et al. Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy. Circulation 2014; 130: 484-495.
18. Hochberg MC,. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1725.
19. Bruce RA,. Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation. Ann Clin Res 1971; 3: 323-332.
20. Rosset A, Spadola L, Ratib O,. OsiriX: An Open-Source Software for Navigating in Multidimensional DICOM Images. J Digital Imaging 2004; 17: 205-216.
21. Katz J, Milliken MC, Stray-Gundersen J, et al. Estimation of human myocardial mass with MR imaging. Radiology 1988; 169: 495-498.
22. Simonetti OP, Finn JP, White RD, Laub G, Henry DA,. "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Radiology 1996; 199: 49-57.
23. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper. J Am Coll Cardiol 2009; 53: 1475-1487.
24. Liu C-Y, Liu YC, Wu C, et al. Evaluation of Age-Related Interstitial Myocardial Fibrosis With Cardiac Magnetic Resonance Contrast-Enhanced T(1) Mapping in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2013; 62: 1280-1287.
25. Kajstura J, Gurusamy N, Ogorek B, et al. Myocyte turnover in the aging human heart. Circ Res 2010; 107 (11): 1374-1386.
26. de Souza RR,. Aging of myocardial collagen. Biogerontology 2002; 3: 325-335.
27. Giunta A, Picillo U, Maione S, et al. Spectrum of cardiac involvement in systemic lupus erythematosus: echocardiographic, echo-Doppler observations and immunological investigation. Acta Cardiologica 1993; 48: 183-197.
28. Sasson Z, Rasooly Y, Chow CW, Marshall S, Urowitz MB,. Impairment of left ventricular diastolic function in systemic lupus erythematosus. Am J Cardiol 1992; 69: 1629-1634.
29. Kass DA, Bronzwaer JGF, Paulus WJ,. What Mechanisms Underlie Diastolic Dysfunction in Heart Failure? Circ Res 2004; 94: 1533-1542.
30. Moreo A, Ambrosio G, De Chiara B, et al. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc imaging 2009; 2: 437-443.
31. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography. J Am Soc Echocardiography 2009; 22: 107-133.
32. Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ,. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magnetic Resonance 2012; 14: 76-76.
33. Asanuma Y, Oeser A, Shintani AK, et al. Premature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus. N Engl J Med 2003; 349: 2407-2415.
34. Flett AS, Hasleton J, Cook C, et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging 2011; 4: 150-156.
35. Kasner M, Westermann D, Steendijk P, et al. Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Diastolic Function in Heart Failure With Normal Ejection Fraction: A Comparative Doppler-Conductance Catheterization Study. Circulation 2007; 116: 637-647.
36. Westenberg JJM,. CMR for Assessment of Diastolic Function. Curr Cardiovasc Imaging Rep 2011; 4: 149-158.
37. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiography 2009; 22: 107-133.